Clinical Trials Sponsored by Quotient Clinical

Total 18962 results

Processa Pharmaceuticals
Quotient Sciences

Completed

Study to Evaluate the PK of Single and Optional Multiple Dosing Regimens of MR Formulations of PCS499 Compared to Trental® Administered to Healthy Subjects

Healthy

United Kingdom
Gubra A/S
Quotient Sciences

Recruiting

A First-In-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB014295

Overweight | Healthy Volunteers

United Kingdom
Angion Biomedica Corp
Quotient Sciences

Not yet recruiting

Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval

Healthy Volunteer

United States
Hubro Therapeutics AS
Quotient Sciences

Completed

Safety and Immune Response to FMPV-1

Colorectal Cancer

United Kingdom
Daiichi Sankyo, Inc.
Quotient Sciences

Completed

A Study to Determine the Absolute Oral Bioavailability of Quizartinib Using a Radiolabeled Microtracer in Healthy Subjects

Healthy Subjects

United Kingdom
MedDay Pharmaceuticals SA
Quotient Sciences

Completed

Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-MD1003 in Healthy Male Subjects

Healthy Volunteers

United Kingdom
Helsinn Healthcare SA
Quotient Sciences

Completed

A Study In Healthy Male Volunteers Designed To Investigate How A Radiolabelled Medicine Is Broken Down And Removed From The Body

Healthy Subjects

United Kingdom
Quantum Genomics SA
Quotient Sciences

Completed

Evaluation of the PK Profile of Firibastat Following Administration of Firibastat Prototype Tablet Formulations

Healthy Males

United Kingdom
Angion Biomedica Corp
Quotient Sciences

Recruiting

A Study to Assess the Absorption, Metabolism and Excretion of [14C]-ANG-3777

Healthy

United Kingdom
Kazia Therapeutics Limited
Quotient Sciences

Completed

Mass Balance Recovery, Metabolite Profile, and Metabolite Identification of [14C]-Paxalisib in Healthy Male Subjects

Healthy

United Kingdom
Actimed Therapeutics Ltd
Quotient Sciences

Completed

Study of Comparative Bioavailability and Pharmacokinetics of ACM-001.1) and Pindolol in Healthy Volunteers (HV)

Cachexia

United Kingdom
Galmed Pharmaceuticals Ltd
Quotient Sciences

Completed

An Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability and Mass Balance of Aramchol

NASH

United Kingdom
Kadmon Corporation, LLC
Quotient Sciences

Completed

Drug-drug Interaction Between Belumosudil, Itraconazole, Rifampicin, Rabeprazole, and Omeprazole in Healthy Volunteers

Autoimmune Diseases | Drug-drug Interaction | Fibrotic Disease

United Kingdom
Baxter Healthcare Corporation
Quotient Sciences

Completed

Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects

Bioequivalance

United States
Neuramedy Co. Ltd.
Quotient Sciences

Not yet recruiting

Single and Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of NM-101

Parkinson Disease

United Kingdom
Galmed Pharmaceuticals Ltd
Quotient Sciences

Completed

A First-in-Human Study of Single and Multiple Doses of Amilo-5MER in Healthy Subjects

Inflammatory Disease

United Kingdom
Kadmon Corporation, LLC
Quotient Sciences

Completed

Human Absorption, Distribution and Metabolism Study (hAME) [14C]-KD025 (KD025-108)

Fibrosis | Autoimmune Diseases

United Kingdom
Kadmon Corporation, LLC
Quotient Sciences

Completed

A Phase I Study to Evaluate the Taste of Belumosudil Oral Suspensions & Assess Relative Bioavailability

Healthy Volunteers

United Kingdom
Corino Therapeutics, Inc.
Quotient Sciences

Completed

A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone

Healthy Volunteers

United Kingdom
Drugs for Neglected Diseases
Quotient Sciences

Completed

Study to Investigate Effect of Food and Safety of a New Formulation of Zoliflodacin

Gonorrhea

United States
Eli Lilly and Company
Quotient Sciences

Completed

A Multiple Dose Study of LY3502970 in Healthy Participants

Healthy

United Kingdom
Senju Pharmaceutical Co., Ltd.
Quotient Sciences

Completed

Single Dose ADME Study of [14C]SJP-0008 in Healthy Male Subjects

Healthy Volunteers

United Kingdom
Qurient Co., Ltd.

Terminated

A Phase 2 Study to Evaluate Biomarker Change, Efficacy, Pharmacokinetics, Safety and Tolerability of Telacebec (Q203) in Covid-19 Patients

COVID-19 Virus Infection

South Africa
Qurient Co., Ltd.

Completed

Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients

Atopic Dermatitis

United States
Qurient Co., Ltd.

Completed

A Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Single Doses of Q203 in Normal, Healthy, Male and Female Volunteers

Healthy Volunteers

United States
Qurient Co., Ltd.

Completed

A Phase 2 Study to Evaluate Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of Telacebec (Q203)

Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TB

South Africa
Qurient Co., Ltd.

Completed

A Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Doses of Q203 in Normal Healthy Male and Female Volunteers

Healthy Volunteers

United States
Qurient Co., Ltd.

Completed

Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients

Moderate to Severe Atopic Dermatitis

United States
Qurient Co., Ltd.

Recruiting

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid Tumor

Solid Tumor | Metastatic Cancer | Advanced Cancer

United States
Reveal Pharmaceuticals Inc.
National Cancer Institute (NCI); Quotient Sciences

Completed

First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent

Healthy

United States
MODAG GmbH
Teva Pharmaceutical Industries, Ltd.; Quotient Sciences; Aptuit

Completed

A Drug-Drug Interaction Study to Assess the CYP1A2 and CYP3A4 Interaction Potential of TEV-56286 (anle138b)

Healthy Volunteers

United Kingdom
Ensysce Biosciences
National Institute on Drug Abuse (NIDA); Quotient Sciences

Completed

Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (MPAR-101)

Pharmacokinetics

United States
Geisinger Clinic
Clinical Innovations

Withdrawn

The Effect of Traxi Panniculus Retractor on Surgical Time at Non-emergent Cesarean Delivery in Obese Women

Obesity

United States
MODAG GmbH
Nottingham University Hospitals NHS Trust; Quotient Sciences; Aptuit

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of anle138b in Parkinson's Disease

Parkinson Disease

United Kingdom
MODAG GmbH
Quotient Sciences; Aptuit (Verona) Srl, an Evotec Company

Completed

A First-in-Human Study of Single and Multiple Doses of anle138b in Healthy Subjects

Healthy Volunteers

United Kingdom
Laboratorio Farmaceutico Ct S.r.l.
Latis S.r.l.; Quotient Bioresearch; Voisin Consulting, Inc.

Completed

Safety and Pharmacodynamic Study of GET 73 in Alcohol Dependent (SPAD)

Alcohol Dependence

United States
Qurient Co., Ltd.
Merck Sharp & Dohme LLC

Recruiting

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

Metastatic Cancer | Advanced Cancer

United States, Korea, Republic of
Qurient Co., Ltd.
Merck Sharp & Dohme LLC

Recruiting

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors

Cervical Cancer | Gastric Cancer | Esophageal Cancer | Hepatocellular Cancer

Korea, Republic of, United States
The Cleveland Clinic
Critical Diagnostics

Completed

Evaluation of ST2 and IL-33 in Patients Presenting to the Emergency Department With Trouble Breathing

Pneumonia | Chronic Obstructive Pulmonary Disease | Asthma | Pulmonary Embolism | Congestive Heart Failure

United States
Medicines for Malaria Venture
GlaxoSmithKline; Quotient Sciences; Swiss Bio Quant; Banook Group; The Doctors Laboratory

Completed

First-in-Human Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV367

Malaria,Falciparum

United Kingdom
Elsan
European Clinical Trial Experts Network; Belledonne clinic

Recruiting

Prospective Evaluation of the Quality of Life of Elderly Patients Undergoing Transfemoral Percutanous Aortic Valve Replacement (TAVI) for the Treatment of Severe Aortic Stenosis. (TAVI QdV)

Quality of Life | Aortic Valve Replacement | Transfemoral Approach

France
Mayo Clinic
Alliance for Clinical Trials in Oncology

Terminated

Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung | Lung Neoplasms

United States
Mayo Clinic
Mayo Clinic Clinic Center for Innovation; Mayo Clinic Center for Clinical and...

Completed

Cardiovascular Health Promotion Among African-Americans by FAITH! (FAITH!)

Cardiovascular Diseases | Smoking Cessation | Hypertension | Obesity | Diabetes | Physical Activity | Diet Modification | Pre Diabetes | Prevention | High Cholesterol
Mayo Clinic
Abbott Medical Devices; Duke Clinical Research Institute

Completed

Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial (CABANA)

Atrial Fibrillation | Arrhythmia

United States
The Cleveland Clinic
Novella Clinical; Heartscape Technologies, Inc.; PharmaVigilant

Terminated

The BEACON Registry: Best Expert Agreement for Care of Occult Myocardial Infarction (MI) Nationally (BEACON)

Chest Pain

United States
Adams Clinical

Completed

Tracking Response to Antidepressants in Advance of Investigational Trials, Relapse Study (TRAIT-RS)

Major Depressive Disorder

United States
Adams Clinical

Recruiting

Tracking Response to Antidepressants in Advance of Investigational Trials (TRAIT)

Major Depressive Disorder

United States
Adams Clinical

Completed

Tracking Response in Advance of Investigational Trials, Borderline Study (TRAIT-BOR)

Borderline Personality Disorder

United States
Delos Clinical

Completed

Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease

Cancer | Venous Thromboembolism | Pulmonary Thromboembolisms
Adams Clinical

Recruiting

Triage Survey for Neurology Research Eligibility (TRIAGE-Neuro)

Alzheimer Disease

United States

Clinical Trials Sponsored by Quotient Clinical

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations